Seven Eight Capital LP Takes Position in Ascendis Pharma A/S

Seven Eight Capital LP purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 18,636 shares of the biotechnology company’s stock, valued at approximately $2,347,000. A number of […]

Related Keywords

Massachusetts , United States , Stifel Nicolaus , Ascendis Pharma , Westfield Capital Management Co , Exchange Commission , First Turn Management , Ascendis Pharmaas Company Profile , Morgan Stanley , Wells Fargo Company , Massachusetts Financial Services Co , Jpmorgan Chase Co , Seven Eight Capital , Free Report , Point Capital , Financial Services , Capital Management , Turn Management , Get Free Report , Visit Holdingschannel ,